Regulation of dopamine signaling in the striatum by phosphodiesterase inhibitors: novel therapeutics to treat neurological and psychiatric disorders.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Central Nervous System Agents in Medicinal Chemistry

• Publication date

  2015-01-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1871524914666141226103421PMID 25540976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease

  2025cites this paper
• The Impaired Response Inhibition and Salience Attribution Model of Drug Addiction: Recent Neuroimaging Evidence and Future Directions.

  2025cites this paper
• The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats

  2024cites this paper
• Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits

  2024cites this paper
• Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.

  2024cites this paper
• Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia

  2023cites this paper
• Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics.

  2023cites this paper
• Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains

  2022cites this paper
• The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.

  2022cites this paper
• Discovery of tetrahydro-β-carboline- and indole-based derivatives as promising phosphodiesterase-4 inhibitors: Synthesis, biological evaluation, and molecular modeling studies

  2022cites this paper
• Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains

  2021cites this paper
• Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

  2021cites this paper
• Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem.

  2020cites this paper
• Inhibition of PDE4 by FCPR16 induces AMPK‐dependent autophagy and confers neuroprotection in SH‐SY5Y cells and neurons exposed to MPP+‐induced oxidative insult

  2019cites this paper
• Dopamine levels in human tear fluid

  2019cites this paper
• Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder

  2018cites this paper
• Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase‐1 improves cognitive performance

  2018cites this paper
• Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress

  2018cites this paper
• Identification of a PDE4-Specific Pocket for the Design of Selective Inhibitors.

  2018cites this paper
• Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease

  2018cites this paper
• Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington’s Disease and Other Neurodegenerative Disorders

  2017cites this paper
• PDE Inhibitors for the Treatment of Schizophrenia.

  2017cites this paper
• The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease

  2017cites this paper
• Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease?

  2016cites this paper
• The Effects of Dopamine Receptor Agonists on the Sleep-Wake Cycle

  2016cites this paper
• Phosphodiesterase regulation of alcohol drinking in rodents.

  2015cites this paper
• Efficacy and Mechanism of Action of Yiru Tiaojing Granule Against Hyperprolactinemia In Vitro and In Vivo

  2015cites this paper